The social and economic consequences of epilepsy: A controlled national study

Epilepsia

Volumn 52, Issue 5, 2011, Pages 949-956

  Jennum, Poul ^a   Gyllenborg, Jesper ^a   Kjellberg, Jakob ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Dansk Sundhedsinstitut   (Denmark)

Author keywords

Economy; Employment; Epilepsy; Social

Indexed keywords

ANTICONVULSIVE AGENT;

ADULT; ANTICONVULSANT THERAPY; ARTICLE; CITIZENSHIP; CONTROLLED STUDY; DENMARK; DISEASE REGISTRY; DRUG COST; ECONOMIC ASPECT; EMPLOYMENT STATUS; EPILEPSY; FEMALE; HEALTH CARE COST; HOSPITALIZATION; HUMAN; INCOME; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PRIORITY JOURNAL; SOCIAL ASPECT; SOCIOECONOMICS; STATISTICS;

ADULT; COST OF ILLNESS; DENMARK; EMPLOYMENT; EPILEPSY; FEMALE; HEALTH CARE COSTS; HEALTH EXPENDITURES; HUMANS; INCOME; MALE; REGISTRIES;

EID: 79955896067     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2010.02946.x     Document Type: Article

References (49)

1. Argumosa A, Herranz JL,. (2004) Childhood epilepsy: a critical review of cost-of-illness studies. Epileptic Disord 6: 31-40. (Pubitemid 38524188)
2. Balabanov PP, Zahariev ZI, Mateva NG,. (2008) Evaluation of the factors affecting the quality of life and total costs in epilepsy patients on monotherapy with carbamazepine and valproate. Folia Med (Plovdiv) 50: 18-23.
3. Beghi E, Frigeni B, Beghi M, De Compadri P, Garattini L,. (2005) A review of the costs of managing childhood epilepsy. Pharmacoeconomics 23: 27-45. (Pubitemid 40194007)
4. Beghi M, Savica R, Beghi E, Nobili A, Garattini L,. (2009) Utilization and costs of antiepileptic drugs in the elderly: still an unsolved issue. Drugs Aging 26: 157-168.
5. Begley CE, Beghi E,. (2002) The economic cost of epilepsy: a review of the literature. Epilepsia 43 (Suppl 4): 3-9. (Pubitemid 34627709)
6. Begley CE, Beghi E, Beran RG, Heaney D, Langfitt JT, Pachlatko C, Silfvenius H, Sperling MR, Wiebe S,. (2002) ILAE Commission on the Burden of Epilepsy, Subcommission on the Economic Burden of Epilepsy: final report 1998-2001. Epilepsia 43: 668-673. (Pubitemid 34627733)
7. Birbeck G, Chomba E, Atadzhanov M, Mbewe E, Haworth A,. (2007) The social and economic impact of epilepsy in Zambia: a cross-sectional study. Lancet Neurol 6: 39-44. (Pubitemid 44880258)
8. Camfield CS, Camfield PR,. (2007) Long-term social outcomes for children with epilepsy. Epilepsia 48 (Suppl 9): 3-5. (Pubitemid 350198217)
9. Cramer JA,. (1997) Quality of life as an outcome measure for epilepsy clinical trials. Pharm World Sci 19: 227-230. (Pubitemid 27450434)
10. Das K, Banerjee M, Mondal GP, Devi LG, Singh OP, Mukherjee BB,. (2007) Evaluation of socio-economic factors causing discontinuation of epilepsy treatment resulting in seizure recurrence: a study in an urban epilepsy clinic in India. Seizure 16: 601-607. (Pubitemid 47300151)
11. De Boer HM, Mula M, Sander JW,. (2008) The global burden and stigma of epilepsy. Epilepsy Behav 12: 540-546.
12. Duh MS, Andermann F, Paradis PE, Weiner J, Manjunath R, Cremieux PY,. (2007) The economic consequences of generic substitution for antiepileptic drugs in a public payer setting: the case of lamotrigine. Dis Manag 10: 216-225. (Pubitemid 47403497)
13. Efron B, Tibshirani RJ,. (2008) An introduction to the bootstrap. Chapman & Hall, London.
14. Ekman M, Forsgren L,. (2004) Economic evidence in epilepsy: a review. Eur J Health Econ 5 (Suppl 1): S36-S42. (Pubitemid 39440396)
15. Elliott JO, Lu B, Shneker B, Charyton C, Layne MJ,. (2009a) Comorbidity, health screening, and quality of life among persons with a history of epilepsy. Epilepsy Behav 14: 125-129.
16. Elliott JO, Lu B, Shneker BF, Moore JL, McAuley JW,. (2009b) The impact of 'social determinants of health' on epilepsy prevalence and reported medication use. Epilepsy Res 84: 135-145.
17. Ettinger AB, Manjunath R, Candrilli SD, Davis KL,. (2009) Prevalence and cost of nonadherence to antiepileptic drugs in elderly patients with epilepsy. Epilepsy Behav 14: 324-329.
18. Forsgren I, Beghi E, Ekman M,. (2005) Cost of epilepsy in Europe. Eur J Neurol 12 (Suppl 1): 54-58. (Pubitemid 40755605)
19. Garcia-Contreras F, Constantino-Casas P, Castro-Rios A, Nevarez-Sida A, Estrada Correa GC, Carlos RF, Guzman-Caniupan J, Torres-Arreola LP, Contreras-Hernandez I, Mould-Quevedo J, Garduno-Espinosa J,. (2006) Direct medical costs for partial refractory epilepsy in Mexico. Arch Med Res 37: 376-383.
20. Gilliam F, Kuzniecky R, Faught E, Black L, Carpenter G, Schrodt R,. (1997) Patient-validated content of epilepsy-specific quality-of-life measurement. Epilepsia 38: 233-236. (Pubitemid 27093337)
21. Hamer HM, Spottke A, Aletsee C, Knake S, Reis J, Strzelczyk A, Oertel WH, Rosenow F, Dodel R,. (2006) Direct and indirect costs of refractory epilepsy in a tertiary epilepsy center in Germany. Epilepsia 47: 2165-2172. (Pubitemid 44952272)
22. Heaney DC, Sander JW,. (2007) The unknown cost of epilepsy misdiagnosis in England and Wales. Seizure 16: 377. (Pubitemid 46614652)
23. Jacoby A, Austin JK,. (2007) Social stigma for adults and children with epilepsy. Epilepsia 48 (Suppl 9): 6-9. (Pubitemid 350198218)
24. Jennum P, Kjellberg J,. (2010) The socio-economical burden of hypersomnia. Acta Neurol Scand 121: 265-270.
25. Jennum P, Knudsen S, Kjellberg J,. (2009) The economic consequences of narcolepsy. J Clin Sleep Med 5: 240-245.
26. Jette N, Quan H, Faris P, Dean S, Li B, Fong A, Wiebe S,. (2008) Health resource use in epilepsy: significant disparities by age, gender, and aboriginal status. Epilepsia 49: 586-593. (Pubitemid 351661050)
27. Kleinman A, Wang WZ, Li SC, Cheng XM, Dai XY, Li KT, Kleinman J,. (1995) The social course of epilepsy: chronic illness as social experience in interior China. Soc Sci Med 40: 1319-1330.
28. Komarek V, Smidova J,. (2007) The psychosocial impact of epilepsy in Czech children: what are causative factors of differences during ten years interval? Epileptic Disord 9 (Suppl 1): S2-S8. (Pubitemid 351346152)
29. Langfitt JT, Holloway RG, McDermott MP, Messing S, Sarosky K, Berg AT, Spencer SS, Vickrey BG, Sperling MR, Bazil CW, Shinnar S,. (2007) Health care costs decline after successful epilepsy surgery. Neurology 68: 1290-1298. (Pubitemid 46625975)
30. Leonardi M, Ustun TB,. (2002) The global burden of epilepsy. Epilepsia 43 (Suppl 6): 21-25. (Pubitemid 35006463)
31. Mistry H, Dowie R, Young TA, Gardiner HM,. (2007) Costs of NHS maternity care for women with multiple pregnancy compared with high-risk and low-risk singleton pregnancy. BJOG 114: 1104-1112. (Pubitemid 47247036)
32. Noronha AL, Borges MA, Marques LH, Zanetta DM, Fernandes PT, de Boer H, Espindola J, Miranda CT, Prilipko L, Bell GS, Sander JW, Li LM,. (2007) Prevalence and pattern of epilepsy treatment in different socioeconomic classes in Brazil. Epilepsia 48: 880-885. (Pubitemid 46763425)
33. Pal SK, Sharma K, Prabhakar S, Pathak A,. (2008) Psychosocial, demographic, and treatment-seeking strategic behavior, including faith healing practices, among patients with epilepsy in northwest India. Epilepsy Behav 13: 323-332.
34. Pena P, Sancho J, Rufo M, Martinez S, Rejas J,. (2009) Driving cost factors in adult outpatients with refractory epilepsy: a daily clinical practice in clinics of neurology in Spain. Epilepsy Res 83: 133-143.
35. Pugliatti M, Beghi E, Forsgren L, Ekman M, Sobocki P,. (2007) Estimating the cost of epilepsy in Europe: a review with economic modeling. Epilepsia 48: 2224-2233. (Pubitemid 350243405)
36. Ribeiro JL, Mendonca D, Martins da Silva A,. (1998) Impact of epilepsy on QOL in a Portuguese population: exploratory study. Acta Neurol Scand 97: 287-294. (Pubitemid 28191919)
37. Sancho J, Pena P, Rufo M, Palacios G, Masramon X, Rejas J,. (2008) Health and non-health care resources use in the management of adult outpatients with drug-resistant epilepsy in Spain: a cost-of-illness study (LINCE study). Epilepsy Res 81: 176-187.
38. Smeets VM, van Lierop BA, Vanhoutvin JP, Aldenkamp AP, Nijhuis FJ,. (2007) Epilepsy and employment: literature review. Epilepsy Behav 10: 354-362. (Pubitemid 46567775)
39. Strzelczyk A, Reese JP, Dodel R, Hamer HM,. (2008) Cost of epilepsy: a systematic review. Pharmacoeconomics 26: 463-476. (Pubitemid 351704857)
40. Thomas SV, Bindu VB,. (1999) Psychosocial and economic problems of parents of children with epilepsy. Seizure 8: 66-69. (Pubitemid 29117012)
41. Thompson PJ, Oxley J,. (1988) Socioeconomic accompaniments of severe epilepsy. Epilepsia 29 (Suppl 1): S9-S18.
42. van Andel J, Zijlmans M, Fischer K, Leijten FS,. (2009) Quality of life of caregivers of patients with intractable epilepsy. Epilepsia 50: 1294-1296.
43. Vera-Llonch M, Brandenburg NA, Oster G,. (2008) Cost-effectiveness of add-on therapy with pregabalin in patients with refractory partial epilepsy. Epilepsia 49: 431-437. (Pubitemid 351294524)
44. Westphal-Guitti AC, Alonso NB, Migliorini RC, da Silva TI, Azevedo AM, Caboclo LO, Sakamoto AC, Yacubian EM,. (2007) Quality of life and burden in caregivers of patients with epilepsy. J Neurosci Nurs 39: 354-360.
45. Whiting P, Gupta R, Burch J, Mota RE, Wright K, Marson A, Weishmann U, Haycox A, Kleijnen J, Forbes C,. (2006) A systematic review of the effectiveness and cost-effectiveness of neuroimaging assessments used to visualise the seizure focus in people with refractory epilepsy being considered for surgery. Health Technol Assess 10: 1-250.
46. Wiebe S,. (2006) Burden of intractable epilepsy. Adv Neurol 97: 1-4.
47. Wilby J, Kainth A, Hawkins N, Epstein D, McIntosh H, McDaid C, Mason A, Golder S, O'Meara S, Sculpher M, Drummond M, Forbes C,. (2005) Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation. Health Technol Assess 9: 1-157.
48. Wilson SJ, Bladin PF, Saling MM,. (2007) The burden of normality: a framework for rehabilitation after epilepsy surgery. Epilepsia 48 (Suppl 9): 13-16. (Pubitemid 350198220)
49. Zachry WM III, Doan QD, Clewell JD, Smith BJ,. (2009) Case-control analysis of ambulance, emergency room, or inpatient hospital events for epilepsy and antiepileptic drug formulation changes. Epilepsia 50: 493-500.